Evidence map›Paper›PMID 29377124›Full record

ReviewJournal of neurochemistry2018

Purinergic signaling in oligodendrocyte development and function.

Taylor G Welsh, Sarah Kucenas

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neurochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Physiology of Oligodendroglia.Advances in neurobiology · 2025
    Review
  4. Article
  5. Adenosine AFrontiers in pharmacology · 2024
    Article
  6. β-carbolines that enhance GABAFrontiers in cellular neuroscience · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Taylor G WelshNeuroscience Graduate Program, Charlottesville, Virginia, USA.
Sarah KucenasNeuroscience Graduate Program, Charlottesville, Virginia, USA.ORCID 0000-0002-1950-751X
Charlottesville Medical Research · US

Funding

Genetic Analysis of Glial Contribution to Peripheral Nervous System AssemblyR01NS072212 · NINDS · UNIVERSITY OF VIRGINIA · PI KUCENAS, SARAH C · 2010 to 2019
$3.5M
Investigating Glial Interactions Across the Motor Exit Point During DevelopmentR21NS092070 · NINDS · UNIVERSITY OF VIRGINIA · PI KUCENAS, SARAH C · 2015 to 2016
$426k
NINDS NIH HHS R01 NS072212NINDS NIH HHS R21 NS092070
6 · The paper itself

Abstract

Myelin, an insulating membrane that enables rapid action potential propagation, is an essential component of an efficient, functional vertebrate nervous system. Oligodendrocytes, the myelinating glia of the central nervous system (CNS), produce myelin throughout the CNS, which requires continuous proliferation, migration, and differentiation of oligodendrocyte progenitor cells. Because myelination is essential for efficient neurotransmission, researchers hypothesize that neuronal signals may regulate the cascade of events necessary for this process. The ability of oligodendrocytes and oligodendrocyte progenitor cells to detect and respond to neuronal activity is becoming increasingly appreciated, although the specific signals involved are still a matter of debate. Recent evidence from multiple studies points to purinergic signaling as a potential regulator of oligodendrocyte development and differentiation. Adenosine triphosphate (ATP) and its derivatives are potent signaling ligands with receptors expressed on many populations of cells in the nervous system, including cells of the oligodendrocyte lineage. Release of ATP into the extracellular space can initiate a multitude of signaling events, and these downstream signals are specific to the particular purinergic receptor (or receptors) expressed, and whether enzymes are present to hydrolyze ATP to its derivatives adenosine diphosphate and adenosine, each of which can activate their own unique downstream signaling cascades. This review will introduce purinergic signaling in the CNS and discuss evidence for its effects on oligodendrocyte proliferation, differentiation, and myelination. We will review sources of extracellular purines in the nervous system and how changes in purinergic receptor expression may be coupled to oligodendrocyte differentiation. We will also briefly discuss purinergic signaling in injury and diseases of the CNS.

Indexed as

AnimalsCell DifferentiationCentral Nervous SystemHumansNeural Stem CellsNeurogenesisOligodendrogliaReceptors, PurinergicSignal TransductionReceptors, PurinergicATPgliamyelinoligodendrocytepurinepurinergic receptors

Identifiers

PMID29377124
PMCPMC5937939
OpenAlexW2793100732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.